Αποτελέσματα Αναζήτησης
21 Σεπ 2021 · Our findings emphasize the imperative of COVID-19 vaccination to prevent hospitalization for COVID-19 treatment and the subsequent susceptibility to hospital-acquired S. aureus co-infection.
12 Νοε 2020 · Bacteremia with S. aureus is associated with high mortality rates in patients hospitalized with COVID-19. Further investigation is warranted to understand the impact of COVID-19 and secondary S. aureus bacteremia. Keywords: bacteremia, COVID-19, SARS-CoV-2, Staphylococcus aureus.
14 Απρ 2021 · Coagulase-negative staphylococci (CoNS) are among the most frequently recovered bacteria in routine clinical care. Their incidence has steadily increased over the past decades in parallel to the advancement in medicine, especially in regard to the utilization of foreign body devices.
7 Οκτ 2022 · COVID-19 patients with bacterial coinfection or secondary infection have a higher in-hospital mortality and longer length of stay, timely and appropriate antibiotic use aided by accurate diagnosis is crucial to improve patient outcome and prevent antimicrobial resistance.
12 Νοε 2020 · Bacteremia with S. aureus is associated with high mortality rates in patients hospitalized with COVID-19. Further investigation is warranted to understand the impact of COVID-19 and secondary S. aureus bacteremia.
31 Ιαν 2023 · Emerging evidence suggests that surges in COVID-19-related hospital admissions are associated with an increase in antibiotic-resistant infections, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. 8,9
15 Δεκ 2020 · Currently, no treatment is very effective in treating the SARS-CoV-2 infection, but the classes of drugs that are mainly used include antiviral agents, inflammation inhibitors, low-molecular-weight heparins, plasma, and hyperimmune immunoglobulins.
